These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15469810)

  • 1. [Asthma and respiratory syncytial virus. New opportunities for therapeutic intervention].
    Mejías A; Chávez-Bueno S; Ríos AM; Fonseca-Aten M; Gómez AM; Jafri HS; Ramilo O
    An Pediatr (Barc); 2004 Sep; 61(3):252-60. PubMed ID: 15469810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-respiratory syncytial virus (RSV) neutralizing antibody decreases lung inflammation, airway obstruction, and airway hyperresponsiveness in a murine RSV model.
    Mejías A; Chávez-Bueno S; Ríos AM; Saavedra-Lozano J; Fonseca Aten M; Hatfield J; Kapur P; Gómez AM; Jafri HS; Ramilo O
    Antimicrob Agents Chemother; 2004 May; 48(5):1811-22. PubMed ID: 15105140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of two neutralizing anti-respiratory syncytial virus (RSV) monoclonal antibodies in the RSV murine model: time versus potency.
    Mejías A; Chávez-Bueno S; Ríos AM; Aten MF; Raynor B; Peromingo E; Soni P; Olsen KD; Kiener PA; Gómez AM; Jafri HS; Ramilo O
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4700-7. PubMed ID: 16251314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A humanized monoclonal antibody against respiratory syncytial virus (palivizumab) inhibits RSV-induced neurogenic-mediated inflammation in rat airways.
    Piedimonte G; King KA; Holmgren NL; Bertrand PJ; Rodriguez MM; Hirsch RL
    Pediatr Res; 2000 Mar; 47(3):351-6. PubMed ID: 10709734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory syncytial virus infections: old challenges and new opportunities.
    Mejías A; Chávez-Bueno S; Jafri HS; Ramilo O
    Pediatr Infect Dis J; 2005 Nov; 24(11 Suppl):S189-96, discussion S196-7. PubMed ID: 16378045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association between respiratory syncytial virus infection and reactive airway disease.
    Piedimonte G
    Respir Med; 2002 Apr; 96 Suppl B():S25-9. PubMed ID: 11996401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Therapeutic Potential of ALX-0171 and Palivizumab against Respiratory Syncytial Virus Clinical Isolate Infection of Well-Differentiated Primary Pediatric Bronchial Epithelial Cell Cultures.
    Broadbent L; Parke HG; Ferguson LJ; Millar A; Shields MD; Detalle L; Power UF
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory syncytial virus persistence: evidence in the mouse model.
    Mejías A; Chávez-Bueno S; Gómez AM; Somers C; Estripeaut D; Torres JP; Jafri HS; Ramilo O
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S60-2. PubMed ID: 18820580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and Evaluation of the Fully Humanized Monoclonal Antibody GD-mAb Against Respiratory Syncytial Virus.
    Tian P; Wang Y; Liu H; Yang Y; Wu X; Wei H; Chen T
    Front Cell Infect Microbiol; 2019; 9():275. PubMed ID: 31417879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance of clinical isolates of respiratory syncytial virus for palivizumab (Synagis)-resistant mutants.
    DeVincenzo JP; Hall CB; Kimberlin DW; Sánchez PJ; Rodriguez WJ; Jantausch BA; Corey L; Kahn JS; Englund JA; Suzich JA; Palmer-Hill FJ; Branco L; Johnson S; Patel NK; Piazza FM
    J Infect Dis; 2004 Sep; 190(5):975-8. PubMed ID: 15295704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model.
    Estripeaut D; Torres JP; Somers CS; Tagliabue C; Khokhar S; Bhoj VG; Grube SM; Wozniakowski A; Gomez AM; Ramilo O; Jafri HS; Mejias A
    J Infect Dis; 2008 Nov; 198(10):1435-43. PubMed ID: 18828742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract.
    Wu H; Pfarr DS; Johnson S; Brewah YA; Woods RM; Patel NK; White WI; Young JF; Kiener PA
    J Mol Biol; 2007 May; 368(3):652-65. PubMed ID: 17362988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory syncytial virus disease: update on treatment and prevention.
    Krilov LR
    Expert Rev Anti Infect Ther; 2011 Jan; 9(1):27-32. PubMed ID: 21171875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge.
    Gilbert BE; Patel N; Lu H; Liu Y; Guebre-Xabier M; Piedra PA; Glenn G; Ellingsworth L; Smith G
    Vaccine; 2018 Dec; 36(52):8069-8078. PubMed ID: 30389195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines.
    Fuentes S; Arenas D; Moore MM; Golding H; Khurana S
    Vaccine; 2017 Jan; 35(4):694-702. PubMed ID: 27989627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis.
    Groothuis JR; Hoopes JM; Hemming VG
    Adv Ther; 2011 Feb; 28(2):110-25. PubMed ID: 21318605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol suppresses persistent airway inflammation and hyperresponsivess might partially via nerve growth factor in respiratory syncytial virus-infected mice.
    Zang N; Li S; Li W; Xie X; Ren L; Long X; Xie J; Deng Y; Fu Z; Xu F; Liu E
    Int Immunopharmacol; 2015 Sep; 28(1):121-8. PubMed ID: 26044349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children.
    Andabaka T; Nickerson JW; Rojas-Reyes MX; Rueda JD; Bacic Vrca V; Barsic B
    Cochrane Database Syst Rev; 2013 Apr; (4):CD006602. PubMed ID: 23633336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Respiratory syncytial virus infections in children.
    Staat MA
    Semin Respir Infect; 2002 Mar; 17(1):15-20. PubMed ID: 11891515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis.
    Robinson KA; Odelola OA; Saldanha I; McKoy N
    Cochrane Database Syst Rev; 2010 Feb; (2):CD007743. PubMed ID: 20166098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.